AVPR2 and Hyponatremia: The effect of hyponatremia on mood disorders and the risk of depression has been also shown by the SALT placebo-controlled randomized trials, which reported a significant improvement in the mental health associated with tolvaptan treatment (a V2 vasopressin receptor antagonist), indicating a detrimental influence of hyponatremia on patients’ mood [28].